 In this study, two drugs which are already approved by FDA Anoro and Arnuity will be administered to patients who are already known to have COPD. While patients are being treated with these two drugs one drug at a time over a month, lung health by using usual testing methods CT scan of the lung, pulmonary function test, and blood test will be assessed in addition to HXe MRI. 